Darrion Mitchell, MD, PhD
College of Medicine
Molecular Carcinogenesis and Chemoprevention
My over-arching interests involve improving prognostic, diagnostic, and treatment responses in head and neck cancer and prostate cancer. My initial focus will be on HPV negative head and neck cancer and the development of new selective therapy either natural or pharmacologically created that will improve our standard of care as well as broaden our treatment of recurrent/resistance disease. In parallel, I also hope to identify molecular signatures/biomarkers that are predictive of treatment outcomes and would enable, personalized health care that is effective and less toxic.